Related Experiment Video
Updated: Sep 8, 2025

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
Jennifer A Karlow1,2, Siddhartha Devarakonda3, Xiaoyun Xing1,2
1Department of Genetics, Washington University School of Medicine, St. Louis, Missouri.
Abstract:
Non-small cell lung cancer (NSCLC) is one of the most commonly diagnosed and deadliest cancers worldwide, with roughly half of all patients initially presenting with both primary and metastatic disease. While the major events in the metastatic cascade have been identified, a mechanistic understanding of how NSCLC routinely and successfully colonizes the brain is largely unknown. Recent studies have begun demonstrating the role of epigenetic misregulation during tumorigenesis and metastasis, including widespread changes in DNA methylation and histone modifications. To better understand the role of altered DNA methylation in NSCLC metastasis to the brain, we measured DNA methylation during disease progression for 12 patients, globally profiling the methylation status of normal lung, primary lung tumor, and brain metastasis samples. The variation in methylation was similar during metastatic spread and primary tumorigenesis but less coordinated across genomic features during metastasis. The greatest recurrent changes during metastatic progression were methylation gains in DNA methylation valleys (DMV) harboring the constitutive heterochromatin mark H3K9me3 as well as bivalent marks H3K27me3 and H3K4me1. In a lymph node-derived cancer cell line, EZH2 binding within DMVs was lost, accompanied by an increase in DNA methylation, exemplifying epigenetic switching. The vast majority of the differentially methylated region-associated DMVs harbored developmental genes, suggesting that altered epigenetic regulation of developmentally important genes may confer a selective advantage during metastatic progression. The characterization of epigenetic changes during NSCLC brain metastasis identified recurrent methylation patterns that may be prognostic biomarkers and contributors to disease progression.
Significance:
Altered DNA methylation in lung cancer brain metastases corresponds with loss of EZH2 occupancy at developmental genes, which could promote stem-like phenotypes permissive of dissemination and survival in different microenvironments.
Insights
Epigenetic changes, specifically DNA methylation gains in specific genomic regions, are observed during non-small cell lung cancer (NSCLC) brain metastasis. These alterations in epigenetic regulation may drive cancer progression and offer potential biomarkers.
Area of Science:
- Cancer Biology
- Epigenetics
- Genomics
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer death, with frequent metastasis to the brain.
- Understanding the mechanisms of NSCLC brain metastasis is crucial for improving patient outcomes.
- Epigenetic dysregulation, including DNA methylation changes, is implicated in cancer development and spread.
Purpose of the Study:
- To investigate the role of altered DNA methylation in NSCLC brain metastasis.
- To identify recurrent epigenetic changes associated with NSCLC progression to the brain.
Main Methods:
- Global DNA methylation profiling of normal lung, primary lung tumor, and brain metastasis samples from 12 NSCLC patients.
- Analysis of DNA methylation patterns in relation to genomic features, including DNA methylation valleys (DMVs) and histone modifications (H3K9me3, H3K27me3, H3K4me1).
- Investigation of EZH2 occupancy and DNA methylation changes in a lymph node-derived NSCLC cell line.
Main Results:
- DNA methylation variations during metastatic spread were similar to primary tumorigenesis but less coordinated.
- Recurrent methylation gains were observed in DMVs harboring H3K9me3, H3K27me3, and H3K4me1 marks during metastatic progression.
- Loss of EZH2 binding in DMVs correlated with increased DNA methylation, suggesting epigenetic switching and altered regulation of developmental genes.
Conclusions:
- Altered DNA methylation patterns, particularly gains in DMVs, are characteristic of NSCLC brain metastasis.
- Epigenetic dysregulation of developmental genes may confer a selective advantage for metastasis and survival.
- Identified methylation patterns may serve as prognostic biomarkers for NSCLC brain metastasis.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

